Logo

Gary Guthart

Nov 08, 2017

Illumina has named Gary Guthart to its board of directors, effective Dec. 1, 2017. Guthart is president and CEO of Intuitive Surgical, which makes robots to assist with minimally invasive surgery. He has held a variety of roles at Intuitive Surgical since 1996 and previously developed foundational technology for computer-enhanced surgery at SRI International, which was formerly the Stanford Research Institute. He also served on the board of directors at Affymetrix from 2009 until it was acquired by Thermo Fisher Scientific in 2016.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.